查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930060

全球軟膠囊市場：市場規模、佔有率、成長率、產業分析、按類型、應用和地區劃分的考量、未來預測（2025-2034）

Softgel Capsules Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 216 Pages | 商品交期: 請詢問到貨日

價格

軟膠囊市場成長因素

預計2025年全球軟膠囊市場規模將達78.7億美元，2026年將達83.2億美元。預計2034年，市場規模將最終成長至134.4億美元，預測期內複合年增長率（CAGR）為6.18%。北美將在2025年以35.60%的市佔率引領市場，主要得益於臨床試驗的增加、強大的研發基礎設施以及主要製藥廠商的強大影響力。預計到2032年，美國市場規模將達到39.2億美元，主要得益於越來越多的臨床研究推動軟膠囊在慢性疾病治療的應用。市場上的主要參與者包括 Capsules (Lonza)、Catalent、Sirio Pharma 和 Aenova Holdings，它們都專注於產品創新和市場擴張。

軟膠囊是一種口服劑型，其核心為半固體或液體，外層包裹著明膠、遮光劑和增塑劑，如山梨糖醇和甘油。這些膠囊具有更高的生物可利用性、穩定性和溶解度，使其適用於藥品、營養保健品和膳食補充劑。預防醫學意識的提高、心血管疾病等慢性病盛行率的上升以及人口老化是推動全球軟膠囊市場發展的關鍵因素。

市場驅動因素

臨床試驗和產品上市數量的增加：越來越多的臨床研究評估軟膠囊在治療慢性病方面的療效，這是推動市場成長的主要因素。例如，2021年8月，InnoPharmax公司進行了一項試驗，評估一種用於治療膽道癌的軟膠囊組合製劑。主要公司的產品創新，例如Catalent公司的OptiGel DR技術（可實現緩釋和腸溶膠囊），也正在推動市場擴張。

植物性膠囊的需求：素食和純素軟膠囊因其天然、不含動物成分、不含麩質、非基因改造且溶解性更佳而日益受到歡迎。消費者認為它們更安全、更有效，尤其是在歐洲、北美和亞太地區，這為新產品線和市場差異化創造了機會。

保健和營養補充劑市場成長：受維生素和補充劑在預防慢性疾病（包括心血管疾病和與年齡相關的健康問題）方面需求不斷增長的推動，保健和營養補充劑細分市場預計將在2026年佔57.23%的市場佔有率。此外，由於慢性病盛行率的上升以及仿製藥和創新製劑獲得監管部門批准，處方軟膠囊製劑正經歷顯著增長。

市場限制因子

專利到期和仿製藥競爭：關鍵藥物專利保護期的結束會對製藥公司的收入產生負面影響，導致仿製藥競爭。這會影響市場動態，也可能影響專利軟膠囊產品的成長潛力。

市場區隔

依類型劃分：市場分為明膠膠囊和非動物源性軟膠囊。 2026年，明膠膠囊佔了最大的市場佔有率，達到85.21%，這主要得益於強勁的研發投入、高產能和成熟的生產流程。非動物性軟膠囊（包括纖維素膠囊和普魯蘭膠囊）由於對純素食產品的需求不斷增長，正經歷穩定增長。

按生產商劃分：製藥公司在2026年佔了57.04%的市場佔有率，這主要得益於其大規模生產和大量的研發投入。膳食補充劑生產商也做出了顯著貢獻，這主要得益於全球範圍內新推出的膳食補充劑產品數量的不斷增長。

依地區劃分：

  • 北美：預計2025年市場規模將達到28億美元，2026年將達到29.7億美元，主要得益於活躍的臨床試驗活動和FDA批准的產品上市。
  • 亞太地區：由於患者群體龐大且製藥公司眾多，預計該市場在預測期內將實現最高的複合年增長率。預計到2026年，中國市場規模將達到6.4億美元，日本將達到4.4億美元，印度將達到2.5億美元。
  • 歐洲：對明膠膠囊研發的投資以及素食軟膠囊技術的創新預計將推動強勁成長。 預計到 2026 年，德國的市場規模將達到 6.3 億美元，英國將達到 4 億美元。
  • 中東、非洲和拉丁美洲：由於慢性病盛行率上升以及膳食補充劑使用率不斷提高，預計這些地區具有很高的成長潛力。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要公司新產品發布
  • 主要國家和地區的監管概況
  • 關鍵產業趨勢：併購、業務合作
  • 新冠疫情對市場的影響

第五章 全球軟膠囊市場分析：洞察與預測 （2021-2034）

  • 市場分析、洞察與預測：依類型劃分
    • 明膠膠囊
    • 非動物性軟膠囊
      • 澱粉
      • 普魯蘭
      • 其他
  • 市場分析、洞察與預測：依應用劃分
    • 處方藥
    • 保健品與膳食補充劑
  • 市場分析、洞察與預測：依製造商劃分
    • 製藥公司
    • 營養保健品公司
    • 其他
  • 市場分析、洞察與預測：按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東及非洲

第六章 北美軟膠囊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲軟膠囊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區軟膠囊市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 印度
    • 中國
    • 日本
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲軟膠囊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲軟膠囊市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區

第十一章 競爭格局分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • Capsugel（龍沙）
    • Sirio Pharma Co., Ltd.
    • Catalent, Inc.
    • Aenova Holding GmbH
    • Fuji Capsule Co., Ltd.
    • CAPTEK Softgel International Inc.
    • Curtis Health Caps
    • EuroCaps Ltd
Product Code: FBI103353

Growth Factors of softgel capsules Market

The global softgel capsules market was valued at USD 7.87 billion in 2025 and is projected to reach USD 8.32 billion in 2026, ultimately expanding to USD 13.44 billion by 2034, reflecting a CAGR of 6.18% during the forecast period. North America dominated the market in 2025 with a 35.60% share, driven by rising clinical trials, strong R&D infrastructure, and a high presence of key pharmaceutical manufacturers. The U.S. market is projected to reach USD 3.92 billion by 2032, supported by the growing number of clinical studies promoting the usage of softgel capsules for chronic ailments. Key players include Capsugel (Lonza), Catalent, Inc., Sirio Pharma, and Aenova Holding GmbH, focusing on product innovation and market expansion.

Softgel capsules are oral dosage forms containing a semi-solid or liquid core encapsulated within gelatin, opacifiers, and plasticizers such as sorbitol or glycerin. These capsules offer enhanced bioavailability, stability, and solubility, making them suitable for pharmaceuticals, nutraceuticals, and dietary supplements. Increasing awareness of preventive healthcare, rising prevalence of chronic diseases such as cardiovascular disorders, and a growing geriatric population are major factors driving the global softgel capsules market.

Market Drivers

Rising Clinical Trials and Product Launches: The increasing number of clinical studies evaluating softgel capsules for treating chronic diseases is a key growth driver. For example, in August 2021, InnoPharmax Inc. sponsored trials to assess softgel combinations for biliary tract cancer treatment. Product innovations by key players such as Catalent's OptiGel DR technology, enabling delayed or enteric-release capsules, further support market expansion.

Demand for Plant-Based Capsules: Vegetarian or vegan softgel capsules are gaining popularity due to their natural, non-animal composition, absence of gluten, GMO-free status, and improved solubility. These capsules are viewed as safer and more effective by consumers, particularly in Europe, North America, and Asia Pacific, creating opportunities for new product lines and market differentiation.

Health & Dietary Supplements Growth: In 2026, the health & dietary supplements segment accounted for 57.23% share, driven by the growing need for vitamins and supplements to prevent chronic diseases, including cardiovascular conditions and age-related health issues. Prescription medicines in softgel form are also witnessing significant growth, supported by chronic disease prevalence and regulatory approvals for generic and innovative formulations.

Market Restraints

Patent Expirations and Generic Competition: Loss of patent exclusivity for leading drugs may negatively impact pharmaceutical companies' revenues, introducing generic competition. This could influence market dynamics and affect growth potential for proprietary softgel products.

Market Segmentation

By Type: The market is segmented into gelatin capsules and non-animal softgel capsules. In 2026, gelatin capsules held the largest market share at 85.21%, driven by robust R&D investments, high production capacity, and established manufacturing processes. The non-animal segment, including cellulose-based and pullulan capsules, is growing steadily due to rising demand for vegan-friendly options.

By Manufacturer: Pharmaceutical companies dominate with 57.04% share in 2026, supported by large-scale production and extensive R&D investments. Nutraceutical companies also contribute significantly, benefiting from the global rise in dietary supplement launches.

By Region:

  • North America: Dominated with USD 2.8 billion in 2025 and projected USD 2.97 billion in 2026, driven by strong clinical trial activity and FDA-approved product launches.
  • Asia Pacific: Expected to record the highest CAGR during the forecast period due to a large patient pool and expansion of pharmaceutical companies. In 2026, China USD 0.64 billion, Japan USD 0.44 billion, and India USD 0.25 billion.
  • Europe: Strong growth due to investments in gelatin capsule research and innovations in vegan softgel technologies. Germany USD 0.63 billion, UK USD 0.4 billion in 2026.
  • Middle East & Africa and Latin America: High growth potential driven by rising chronic disease prevalence and increasing dietary supplement adoption.

Competitive Landscape

The global market is moderately consolidated, with Capsugel (Lonza) and Catalent, Inc. leading in revenue and product innovation. Key industry developments include the launch of Amneal Pharmaceuticals' Icosapent ethyl softgel in December 2023 and Roquette's LYCAGEL PREMIX in November 2021. Companies are focusing on expanding geographic presence, pipeline development, and advanced manufacturing technologies.

Conclusion

The global softgel capsules market is expected to grow from USD 7.87 billion in 2025 to USD 13.44 billion by 2034, driven by rising clinical trials, growing chronic disease prevalence, demand for plant-based capsules, and increasing adoption of dietary supplements. North America leads the market, while Asia Pacific is poised for the fastest growth. Gelatin capsules dominate, supported by R&D and manufacturing capacities, whereas non-animal capsules are gaining traction due to consumer preference. The market outlook remains strong as key players focus on innovation, regulatory approvals, and global expansion, ensuring sustained growth and enhanced product availability worldwide.

Segmentation By Type

  • Gelatin Capsules
  • Non-animal Softgel Capsules
    • Starches
    • Pullulan
    • Others

By Application

  • Prescription Medicines
  • Health & Dietary Supplements

By Manufacturers

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Others

By Region

  • North America (By Type, By Application, By Manufacturers, and By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • India
    • China
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. New Product Launch, By Key Players
  • 4.2. Overview of Regulatory Scenario, By Key Countries/ Regions
  • 4.3. Key Industry Developments-Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of Covid-19 on the Market

5. Global Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Gelatin Capsules
    • 5.1.2. Non-animal Softgel Capsules
      • 5.1.2.1. Starches
      • 5.1.2.2. Pullulan
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Prescription Medicines
    • 5.2.2. Health & Dietary Supplements
  • 5.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 5.3.1. Pharmaceutical Companies
    • 5.3.2. Nutraceutical Companies
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Gelatin Capsules
    • 6.1.2. Non-animal Softgel Capsules
      • 6.1.2.1. Starches
      • 6.1.2.2. Pullulan
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Prescription Medicines
    • 6.2.2. Health & Dietary Supplements
  • 6.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 6.3.1. Pharmaceutical Companies
    • 6.3.2. Nutraceutical Companies
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Gelatin Capsules
    • 7.1.2. Non-animal Softgel Capsules
      • 7.1.2.1. Starches
      • 7.1.2.2. Pullulan
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Prescription Medicines
    • 7.2.2. Health & Dietary Supplements
  • 7.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 7.3.1. Pharmaceutical Companies
    • 7.3.2. Nutraceutical Companies
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Gelatin Capsules
    • 8.1.2. Non-animal Softgel Capsules
      • 8.1.2.1. Starches
      • 8.1.2.2. Pullulan
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Prescription Medicines
    • 8.2.2. Health & Dietary Supplements
  • 8.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 8.3.1. Pharmaceutical Companies
    • 8.3.2. Nutraceutical Companies
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Gelatin Capsules
    • 9.1.2. Non-animal Softgel Capsules
      • 9.1.2.1. Starches
      • 9.1.2.2. Pullulan
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Prescription Medicines
    • 9.2.2. Health & Dietary Supplements
  • 9.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Nutraceutical Companies
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Gelatin Capsules
    • 10.1.2. Non-animal Softgel Capsules
      • 10.1.2.1. Starches
      • 10.1.2.2. Pullulan
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Prescription Medicines
    • 10.2.2. Health & Dietary Supplements
  • 10.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 10.3.1. Pharmaceutical Companies
    • 10.3.2. Nutraceutical Companies
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Capsugel (Lonza)
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Sirio Pharma Co., Ltd.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Catalent, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. Aenova Holding GmbH
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Fuji Capsule Co., Ltd.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. CAPTEK Softgel International Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. Curtis Health Caps
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. EuroCaps Ltd
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 2: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 3: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 5: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 6: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 7: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 8: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 9: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 10: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 12: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 13: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 15: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 17: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 18: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 20: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 23: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 25: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 27: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 28: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 30: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Softgel Capsules Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 2: Global Softgel Capsules Market Value Share (%), By Type, 2025 & 2034
  • Figure 3: Global Softgel Capsules Market Value Share (%), By Application, 2025 & 2034
  • Figure 4: Global Softgel Capsules Market Value Share (%), By Manufacturers, 2025 & 2034
  • Figure 5: Global Softgel Capsules Market Value (USD billion), By Region, 2025 & 2034
  • Figure 6: North America Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 7: North America Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 8: North America Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 9: North America Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 10: North America Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 11: North America Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 12: North America Softgel Capsules Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Softgel Capsules Market Value Share (%), By Country, 2025
  • Figure 14: Europe Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 15: Europe Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 16: Europe Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 17: Europe Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 18: Europe Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 19: Europe Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 20: Europe Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 21: Europe Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 22: Asia Pacific Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 23: Asia Pacific Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 24: Asia Pacific Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 27: Asia Pacific Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 28: Asia Pacific Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Latin America Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 31: Latin America Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 32: Latin America Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 33: Latin America Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 34: Latin America Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 35: Latin America Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 36: Latin America Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 39: Middle East & Africa Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 40: Middle East & Africa Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 41: Middle East & Africa Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 42: Middle East & Africa Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 43: Middle East & Africa Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 44: Middle East & Africa Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 46: Global Softgel Capsules Market Share (%), By Company, 2025